You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 17, 22 SEPTEMBER 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIAL
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Colon Cancer Reduction

Questions About Implementation of Proven Techniques

James R. Marshall, PhD; David S. Alberts, MD; Richard E. Sampliner, MD

Arch Intern Med. 1997;157(17):1919-1920.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

TODAY MEDICINE has at its disposal the means to dramatically reduce both the incidence of and mortality from colorectal cancer1-3; if we make this a health care priority, within 10 years colorectal cancer could be a minor contributor to the total cancer burden.

Although ongoing chemoprevention trials—of diet modification,4 calcium carbonate, folate and nonsteroidal anti-inflammatory drugs (E. R. Greenberg, MD, oral communication, March 23, 1997), wheat bran fiber,5 and ursodeoxycholic acid6—may point the way toward primary preventive strategies, screening at present appears our best weapon against colon cancer. The recent acrimonious debates over the value of mammography hinge largely on the modesty of its effects in lowering mortality from breast cancer: the effects of colorectal cancer screening are not modest.

Our immediate challenge is to organize our screening tools—fecal occult blood testing (FOBT), flexible sigmoidoscopy (FS), and colonoscopy—to lessen the colon cancer burden in the most . . . [Full Text PDF of this Article]


Author Affiliations

Arizona Cancer Center Arizona Health Sciences Center 1501 N Campbell Ave Tucson, AZ 85724 Dr Sampliner is also with the Veterans Affairs Hospital, Tucson.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Endoscopists Need to Clean Up Their Act—Literally
Dee A. Knapp, Robert J. Michocki, and David A. Mays
Arch Intern Med. 1998;158(8):928.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.